Management of severe malaria is an increasing problem worldwide. This paper reviews the pathophysiology and management documenting two years' experience of admissions of severe malaria to an ICU in a non-endemic area.
The global incidence of malaria is increasing at an alarming rate and each year an estimated 300 million people will contract the disease 1 . Malaria is predominantly a disease of the Third World with approximately one million deaths occurring annually in Africa alone 2 . Severe malaria is not uncommon in tourists and workers returning to non-endemic areas from malaria areas.
World Health Organisation criteria 3 for the definition of severe malaria may provide a useful guide for ICU admission and admission is recommended for patients presenting with any one of the features listed.
The object of this study was to review the clinical profiles and therapy instituted for patients with severe malaria admitted to an ICU outside a malaria endemic area and identify risk factors for unfavourable outcome.
PATIENTS AND METHODS
Baragwanath Hospital is a 3,000 bed hospital outside Johannesburg which serves a population of approximately four million people in a non-malaria area. It has a 24 bed multidisciplinary ICU which receives medical and surgical, adult and paediatric patients. It has full-time specialist nursing and medical staff. We reviewed the clinical profiles and therapy of 28 consecutive patients with severe and complicated malaria admitted to Baragwanath ICU over a two-year period from January 1993 to December 1994.
All patients were treated with appropriately dosed intravenous quinine therapy (see DISCUSSION) and standard intensive care support including inotropic agents, ventilatory support and continuous venovenous haemodiafiltration where appropriate.
On admission to the Intensive Care Unit all suspected malaria patients have blood taken for a full blood count, urea and electrolytes, liver function tests, a coagulation profile, a thick blood smear for parasite count and arterial blood gas and lactate estimations. Arterial blood gas and lactate analysis is performed in the unit on bedside machines that have regular quality control by in-house qualified, registered technicians. All unstable patients have two-tofour-hourly arterial blood gas and lactate analysis.
Other special investigations are performed as deemed clinically indicated.
For this study data retrieved included: 1. age, sex; 2. worst Glasgow Coma Score (GCS), Apache II score (or PRISM score in the children), and arterial lactate in the first 24 hours after ICU admissions; 3. haemoglobin level, coagulation screen, platelet count, serum creatinine, liver function tests, parasite count on admission; 4. the requirement for dialysis, inotropic support, artificial ventilation during the admission; 5. worst Acute Lung Injury (ALI) 4 score during the admission; and 6. ICU outcome and length of stay.
Definition of cerebral malaria has traditionally been by use of the WHO criterion of "unrousable coma not attributable to any other cause". We found this to be too vague and not useful and therefore the Glasgow Coma Score was used to follow the level of consciousness.
The data were analysed to assess predictors of mortality. Student's t-test for individual variables was used to test the significance.
RESULTS
All patients had clinical or laboratory features compatible with the WHO defining criteria for severe malaria with two or more manifestations of severe disease ( Table 1 ). All patients acquired disease outside South Africa, predominantly in Mozambique, in areas of high chloroquine resistance.
The clinical laboratory and intensive care outcome data are shown in Tables 2 and 3 . Three patients were pregnant. Four patients were less than five years of age. HIV status was not routinely identified but four patients were shown to be antibody positive (three survived and one died).
Plasmodium falciparum was identified in all cases with a mean parasite count of 24.8%. Parasitaemia greater than 5% was present in 22/28 (87%) of the patients, the highest parasitaemia being 71%.
Seventy-five per cent of patients (21/28) showed some disturbance of consciousness with no difference in worst Glasgow Coma Score between survivors and non-survivors (Table 3) . No neurological sequelae were noted in the survivors at discharge from ICU.
A diagnosis of acute respiratory distress syndrome (ARDS) was made in 13 patients using the expanded definition of acute lung injury; chest X-ray findings of alveolar infiltrates, hypoxaemia, reduced compliance and the requirements for PEEP 4 . Eight of these patients died.
Seventeen patients had renal failure 3 with urea >21 mmol/l and creatinine >250 µmol/l. Twelve patients were dialysed using continuous veno-venous haemodiafiltration (CVVHD).
Haematological abnormalities included laboratory evidence of disseminated intravascular coagulation in five of the patients and two patients had clinical bleeding. All patients had thrombocytopenia but this 218 L. BLUMBERG, R. P. LEE ET AL Anaesthesia and Intensive Care, Vol. 24, No. 2, April 1996 Hb = Haemoglobin (g%); WCC = white cell count (10 3 /l); Plat = Platelets (10 3 /l); CRT = Creatinine (µmol/l); GCS = Glasgow Coma Score; Arterial lactate (mmol/l); BE = Base Excess (mmol/l); ALI = Acute Lung Injury. is a common finding and is not an indicator of severity of disease. Anaemia with Hb <10g% occurred in 18 patients, mainly children, and Hb <5g% in three. Hypoglycaemia was not a major problem due to monitoring and early glucose infusion. Mortality in pregnant patients was 100% and foetal death occurred in all three patients. A delay in diagnosis and treatment of malaria occurred, with admission initially to the gynaecologists and treatment for intra-uterine sepsis. The overall mortality was 8/28 (28.5%). These patients had hypoxia and hypotension unresponsive to therapy at time of death.
The four maediatric patients were less than five years of age and all survived to leave the ICI. As expected in this group the major complications were disturbed level of consciousness, severe anaemia associated wiith pulmonary oedema, and hypoglycaemia (Tables 2 and 3) .
Of all the criteria we examined as predictors of outcome, only base excess, arterial lactate and Apache II score in the first 24 hours showed any correlation with mortality (Table 4 ). Notably depressed cerebral function as assessed by GCS did not correlate withy mortality and in fact GCS was slightly lower in the survivors. Infact, several patients with worst GCS less than 19 on admission were discharged from the ICU without any demonstrable cerebral sequelae.
DISCUSSION
Malaria transmission occurs in more than 100 countries including Africa, Asia, Latin America and the Caribbean 3 . It also occurs in other parts of the world 5 as people travel back from infected areas. Malaria occurs as an acute and chronic disease caused by the obligate intracellular protozoa of the genus Plasmodium, of which there are four species: P. malaria, P. Vivax, P. ovale and P. falciparum. Virtually all deaths are due to P.falciparum infection which predominates in Africa and New Guinea and occurs commonly in South America and Southeast Asia. Predicted mortality for patients with severe malaria in health care facilities in rural areas is approximately 75% compared with 20% mortality in various series of patients treated in sophisticated ICUs 3 .
Pathogenesis
Malaria is transmitted by the bite of an infected female Anopheles mosquito. Sporozoites, which form the infective stage of the parasite, are injected by the mosquito into the blood stream from the salivary glands of the mosquito during feeding. Many sporozoites enter the liver where asexual multiplication occurs to produce thousands of merozoites which then invade erythrocytes forming trophozoites. These grow then undergo nuclear division producing and releasing merozoites into the circulation, a process which is continuously repeated.
The primary event in the pathogenesis of severe P.falciparum infection is thought to be adherence of trophozoite and schizont-infected erythrocytes to capillary endothelium, a process known as sequestration 6 . The membrane glycoprotein CD36 and the multifunctional glycoprotein thrombospondin have been implicated as receptors as has variably glycosylated glycoprotein, ICAM-1 7 , which is widely distributed on capillary endothelium. Receptor levels can be up-regulated in response to mediators of sepsis including tumour necrosis factor (TNF), interleukin-1 and gamma-interferon 8 .
Particularly high levels of TNF have been noted in patients with cerebral malaria and are significantly associated with death, regardless of the level of parasitaemia 9 . Massive concentrations of TNF may be released into the systemic circulation after large bursts of schizont rupture. This may induce hypotension, lactic acidosis, septic shock, mucosal gut damage, increased pulmonary microvascular permeability and neutrophil aggregation in the lung 10 .
Clinical Features
The usual features of malaria are generally nonspecific, consisting of fever, malaise, myalgia and headache. In an endemic area this is commonly attributed to malaria but a recent history of travel to such an area should also alert the physician to the possibility of malaria. Due to increasing resistance, even prophylaxis may not always prevent infection. Although a very high temperature (>40°C) is typically associated with severe falciparum malaria the patient is often apyrexial when examined 11 . In many parts of the world, cerebral complications are the commonest presenting symptoms 3 . Hepatomegaly or splenomegaly can be found in approximately onethird of patients 3 .
Diagnosis
A definitive diagnosis of malaria can only be made by microscopic detection of parasites in the peripheral blood. A thick blood film enables better detection at low parasitaemias but their reliable examination requires greater skill. It should be remembered that the degree of parasitaemia may not correlate with the other markers of disease severity, particularly in those patients who normally reside in an endemic area. Errors in microscopy can occur and patients in whom repeated blood films are negative and a strong clinical suspicion of disease exists should have a fine needle bone marrow aspiration.
A high parasite count usually suggests severe disease in the non-immune, whereas a low count does not exclude severe disease. This is borne out in our study, where patients showed a wide range of parasite counts (1-71%) with no relationship to mortality ( Table 3) .
Complications of severe P. falciparum malaria infection
Cardiovascular
Assessment of myocardial function has typically shown an elevated cardiac index (>4.5 litres/min/m 2 ), low systemic vascular resistance and low or normal pulmonary artery pressures 12 . Despite this, early pathological studies described blocking of the coronary radicles with parasites and pigments, fatty degeneration of the myocardium and myocardial changes similar to those found in diphtheritic myocarditis 13 . In our series 13 patients required inotropic agents for hypotension and in 7/8 nonsurvivors the terminal event was associated with resistant hypotension.
Pulmonary
Respiratory failure resulting from pulmonary oedema and/or ARDS has an extremely high mortality 14 as also noted in our study. It occurs late in the illness and may be worsened by fluid loading. Pulmonary oedema can occur in the presence of a normal or low pulmonary artery wedge pressure (PAWP) 15 but iatrogenic fluid overload may contribute as Charoepan documented initially high pulmonary capillary wedge pressures in six patients out of 11 12 and a positive fluid balance usually precedes the onset of pulmonary oedema in falciparum malaria. As a substantial pro-portion of patients with P. falciparum malaria present with oliguria and hyponatraemia, in the presence of a marked pyrexia and vomiting there is a temptation to fluid load the patient. Our experience suggests that this should be avoided as the renal failure that occurred in our patients proved easier to treat and recovered, yet the ARDS was the major cause of death. We therefore suggest the early use of inotropic agents in this setting for low blood pressure.
Cerebral
Cerebral manifestations are common and include coma, confusion and fitting. Warrell had recommended a research definition of cerebral malaria requiring the presence of "unrousable coma" 3 . We feel this definition is insensitive and inappropriate in the clinical setting and would prefer a broader definition: "Disturbed consciousness, confusion or convulsions not explained by hypoglycaemia or other metabolic abnormality". With proper airway care and support, our results suggest that cerebral problems are not associated with higher mortality. Previous reports of high mortality associated with cerebral malaria may be explained by non-availability of intensive care facilities for management of airway and breathing 16 .
Renal
Oliguric renal failure is usually due to acute tubular necrosis. Non-oliguric acute renal failure has been reported 17 . Renal dysfunction is most often reversible 3 .
Haematological
Anaemia is common although many severe cases present without this criterion 18 . Anaemia is due to destruction of red cells and marrow dysplasia and correlates with the degree of parasitaemia and total serum bilirubin levels 3 . Thrombocytopenia is common in both mild and severe falciparum malaria but is not usually associated with bleeding or correlated with disease severity 19 . DIC is reported in less than 10% of patients with severe malaria.
Liver
Jaundice and deranged liver function tests are extremely common findings in patients with severe malaria 17 and generally require no specific treatment. Alteration in metabolic clearance of antimalarial drugs and lactate, abnormalities of coagulation and hypoalbuminaemia are possible effects. Jaundice is mainly due to intravascular haemolysis and levels of total and indirect bilirubin are elevated. Decreased hepatic flow has been demonstrated during severe malaria 20 , probably due to sequestration in the portal circulation.
Metabolic acidosis
The strong association among acid-base status, disease severity and mortality has been previously noted 21 . We found that worst arterial lactate and base excess in the first 24 hours were the most accurate predictors of death. Perhaps this is due to poor perfusion to tissues from sequestration of red blood cells in the circulation, microcirculatory problems due to cytokines or defects in energy-producing pathways 22 .
Hypophospataemia
Hypophosphataemia, perhaps caused by intravenous glucose administration and quinine-induced hyperinsulinaemia 23 , may contribute to disturbance of cerebral function, platelet function and haemolysis.
Hypoalbuminaemia
Hypoalbuminaemia is common in patients with severe malaria perhaps produced by the cytokine induced acute phase reaction. Malnutrition does not appear to increase susceptibility to severe malaria 24 .
Pregnancy
In pregnant women mortality from malaria is high, as we observed, although no reason has been found for this. The problems of hypoglycaemia, cerebral malaria and ARDS are exaggerated 3 .
TREATMENT

Basic supportive care (a) Respiratory
Meticulous intensive care of airway and breathing is essential. The patient may need to be intubated because of impaired consciousness or because of acute lung disease. Patients with hypoventilation associated with cerebral malaria will require IPPV.
(b) Cardiovascular
Increasing use of pulmonary artery catheterization and echocardiography will enable accurate documentation of cardiovascular status in malaria and guide appropriate inotropic therapy. In the absence of invasive monitoring it is important to closely monitor respiratory status if fluid loading is required for treatment of oliguria or hypotension.
Continuous electrocardiographic monitoring is mandatory for patients receiving quinidine.
(c) Fluid balance
The emphasis is on maintaining as low a pulmonary capillary wedge pressure as is compatible with adequate cardiac output and renal output. In areas where this is technically not possible meticulous control of fluid balance and respiratory status remain the only answer. If fluid loading is associated with worsening respiratory status, fluid restriction will be necessary.
(d) Renal support
The early institution of continuous veno-venous haemodiafiltration for the management of renal failure offers several advantages in the management of severe malaria. Fluid balance is easier to manipulate, the risk of fluid overload obviated and it provides a means whereby circulating monokines and TNF may be removed 10 . Haemodynamic stability can be maintained and adequate parenteral nutrition guaranteed if needed without risk of fluid overload. Furthermore, exchange transfusion can easily be performed concurrently via the existing venous access used for dialysis.
(e) Haematological support
Blood transfusion should be considered if the haematocrit falls to 20%.
(f) Hypoglycaemia
Hypoglycaemia in severe malaria may occur as a result of impaired gluconeogenesis, increased glucose consumption and/or quinine induced hypoglycaemia. It is often masked by other effects of malaria and therefore difficult to detect.
Specific pharmacological treatment
Intravenous quinine sulphate remains the treatment of choice in severe falciparum malaria and is generally well tolerated. Ideally a loading dose of 15-20 mg salt/kg, reconstituted in either 5% dextrose or 0.9% saline, should be given over 30 minutes by infusion pump followed immediately by 10 mg salt/kg over four hours 25 . Patients who have received quinine prior to intensive care admission should not be given the loading dose. The maintenance dose of quinine is 10 mg salt/kg administered eight-hourly at infusion rates of 2-6 mg salt/kg/hr. The therapeutic range of quinine is unknown although plasma levels of 8-20 mg/l have been reported to be safe and effective 26 . In renal failure the dose should be reduced by one-third to one-half on the third day of therapy 3 . We know of no data on the clearances of quinine by haemodialysis (neither intermittent nor continuous techniques). Commonly occurring side-effects of quinine therapy include cinchonism and hypoglycaemia 27 . Signs of severe quinine toxicity may occur with plasma concentrations over 20 mg/l and include myocardial conduction abnormalities, hypotension, blindness, deafness and coma 28 . Treatment should be continued for a total of ten days and parenteral quinine changed to oral quinine as soon as the patient can tolerate oral fluids.
Quinidine, the dextrorotary optical isomer of quinine, may be more readily available but is more toxic. Its efficacy has been well documented in Thailand where decreasing sensitivity to quinine has prompted search for more potent agents 29 . In vitro studies have shown the parasite to be two to three times more sensitive to quinidine than to quinine. The major side-effects of quinidine are cardiac conduction abnormalities, related to a prolongation of the QT c interval, and hypotension 29 . The recommended dosage regimen of quinidine is similar to that of quinine although continuous infusion of quinidine gluconate may offer some advantages with respect to decreased toxicity 30 .
The most promising new antimalarial drugs are the Artemesinin compounds which are derived from the Chinese medicinal herb qing hao. These compounds clear parasitaemia more rapidly than any other antimalarial drug with no apparent toxicity except for rare transient first degree heart block and decrease in neutrophil or reticulocyte count 31 . Coma resolution times have been significantly shortened 32 .
As recommended our drug of choice for treatment was IV quinine with a loading dose to rapidly achieve therapeutic levels.
Exchange transfusion
Although there are still no controlled trials to conclusively support the use of exchange transfusion, its theoretical benefits include rapid reduction in parasite load without the haemolysis associated with medical treatment and a reduction in circulating cytokines and parasitic toxins.
Hyperparasitaemia has been considered an indication at levels ranging from 10% to 50% despite reported survival rates of over 80% without exchange transfusion in patients with severe malaria 34 . Short supply of blood, however, and the increased prevalence of HIV infection may exclude exchange transfusion in many Third World regions.
We carried out four exchange transfusions. Two of these patients died.
CONCLUSION
In view of the worldwide increase in malaria and in particular with increasing travel, malaria may well become more common in First World environments.
Recently Baragwanath Intensive Care Unit has managed 28 patients with severe malaria, but despite intensive treatment, mortality was almost 30%. Pregnancy was a major risk factor for unfavourable outcome. ARDS causing irreversible and untreatable respiratory failure was the most important cause of death and occurred in all eight patients who died. The WHO criteria for severe malaria are important indicators of morbidity. With appropriate management of the airway and ventilatory requirements of patients with malaria and cerebral disturbance we were able to prevent sequelae in this subgroup of malaria. High Apache II scores, high arterial lactate and negative base excess in the first 24 hours of admission correlated with mortality. We suggest that these parameters should be utilized more widely in the assessment of the severity of malaria and be used as part of ICU admission criteria for patients with severe malaria.
